Preparing for an evolving regulatory landscape to successfully commercialize cell and gene therapies

Cell and gene therapies are progressing through clinical trials and driving towards commercialization at a rapid pace. As a result, regulatory agencies have had to pivot quickly to provide guidance to support the pace of development.

Based on extensive experience supporting early-stage and clinical-stage companies through the drug development and approval process, the webinar will provide critical guidance for navigating regulatory requirements to accelerate the commercialization process and get much-needed therapies to patients sooner.

Listen to this webinar to hear industry expert, Monica Commerford, Ph.D.

Related Sites

Additional Resources